Rhapsido 25 MG tablet UU 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FCZ6T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,437
Award facts
- Contract value 100% obligated
- $11,436.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Rhapsido 25 mg tablets in quantities of 60 units. This firm fixed-price delivery order, valued at $11,436.53, is scheduled for completion by January 15, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made on a competitive, non-set-aside basis and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 prime vendor agreement that extends through December 2026 and serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor providing critical medical procurement services to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs. The company's extensive portfolio includes specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Rhapsido reflects the company's ongoing role in supplying essential pharmaceuticals to the military healthcare system through its comprehensive global pharmaceutical support vehicle with the DLA.
Quick answers
Who was awarded contract SPE2DR26FCZ6T?
SPE2DR26FCZ6T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FCZ6T worth?
The government has obligated $11,437 on SPE2DR26FCZ6T.
Is contract SPE2DR26FCZ6T an order under another contract?
Yes. SPE2DR26FCZ6T is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCZ6T competed?
The extent of competition for SPE2DR26FCZ6T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award